TYRA-300 API Powder

TYRA-300 is a selective inhibitor designed to target Fibroblast Growth Factor Receptor 3 (FGFR3), a receptor involved in cellular growth signaling and bone development. FGFR3 plays an important role in regulating cellular proliferation and differentiation, while abnormal FGFR3 activation may be associated with altered cellular growth processes.

TYRA-300 is intended as a research-use compound for studies investigating FGFR3-mediated signaling, receptor biology, cellular growth pathways, and related molecular mechanisms.

Key Features

Research Applications

TYRA-300 may be used in research involving:

• FGFR3 receptor signaling
• Fibroblast growth factor pathway research
• Cellular proliferation and differentiation studies
• Molecular investigations of FGFR3 activity
• Receptor-targeted drug discovery
• Preclinical oncology and cell-signaling research
• Studies of biological processes associated with abnormal FGFR3 activation
• 

Why Choose TYRA-300?

Selective FGFR3 Targeting
Designed around FGFR3 as a specific molecular target for research into receptor-mediated signaling.

Pathway-Focused Research
Suitable for investigations of FGFR3-dependent cellular signaling and downstream biological processes.

Versatile Research Utility
Can support laboratory studies spanning receptor biology, cellular signaling, proliferation, differentiation, and drug-discovery research.